Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2387990 | 0.97 | SLC6A4 (0.48) | DPP4OPRM1SLC6A4SLC6A2SLC6A3 | |
| Hydrogen Peroxide SCHEMBL9938277 | 0.97 | AKR1C1 (0.50) | DPP4AKR1C1OPRM1OPRK1OPRL1 | |
| SCHEMBL19382448 | 0.97 | SLC6A4 (0.48) | DPP4OPRM1SLC6A4SLC6A2SLC6A3 | |
| Ammonia Solution, Strong SCHEMBL20553594 | 0.97 | DPP4 (0.45) | DPP4AKR1C1OPRM1OPRK1OPRL1 | |
| SCHEMBL353050 | 0.95 | OPRL1 (0.46) | DPP4AKR1C1OPRM1OPRK1OPRL1 | |
| SCHEMBL498014 | 0.89 | OPRM1 (0.50) | OPRM1OPRK1OPRL1 | |
| Ammonia Solution, Strong SCHEMBL9556021 | 0.86 | OPRM1 (0.48) | OPRM1OPRK1OPRL1 | |
| SCHEMBL10990510 | 0.85 | AKR1C1 (0.41) | AKR1C1SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL10602015 | 0.83 | ESR1 (0.42) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL14704743 | 0.81 | OPRM1 (0.53) | OPRM1SLC6A4SLC18A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 742 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059684-A | Raw material composition for organic synthesis reaction, application thereof, hydrogenated terphenyl synthetic heat conduction oil and preparation method thereof | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120059683-A | Synthetic heat conduction oil and application | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| US-10710945-B2 | Aromatic compositions and methods for obtaining them | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-105829273-B | Process for preparing phenol and/or cyclohexanone | 埃克森美孚化学专利公司 | 2019-05-28 | — | — | CN | claimed |
| US-10259759-B2 | Cyclohexylbenzene composition | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-16 | — | — | US | claimed |
| US-20180237361-A1 | Aromatic Compositions and Methods for Obtaining Them | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-08-23 | — | — | US | claimed |
| US-9908829-B2 | Process for making phenol and/or cyclohexanone | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-03-06 | — | — | US | claimed |
| WO-2017052790-A1 | AROMATIC COMPOSITIONS AND METHODS FOR OBTAINING THEM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-03-30 | — | — | WO | claimed |
| US-20170057895-A1 | Phenol Composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-03-02 | — | — | US | claimed |
| US-20170001930-A1 | Cyclohexylbenzene Composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-01-05 | — | — | US | claimed |
| WO-2010098916-A2 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-09-02 | — | — | WO | claimed |
| WO-2009128984-A1 | PROCESS FOR PRODUCING CYCLOHEXYLBENZENE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-10-22 | — | — | WO | claimed |
| EP-1663962-A4 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORP (US) | 2007-08-22 | — | — | EP | claimed |
| JP-2007503392-A | — | — | 2007-02-22 | — | — | JP | claimed |
| EP-1663962-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORPORATION (US) | 2006-06-07 | — | — | EP | claimed |
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | DENDREON CORPORATION (US) | 2005-03-10 | — | — | US | claimed |
| WO-2005020897-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION | DENDREON CORPORATION (US) | 2005-03-10 | — | — | WO | claimed |
| EP-1053224-B1 | BIPHENYLSULFONYL CYANAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS A MEDICAMENT | AVENTIS PHARMA GMBH (DE) | 2002-08-21 | — | — | EP | claimed |
| US-6369069-B1 | CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-09 | — | — | US | claimed |
| US-3959226-A | ISOMERIZATION; FRIEDEL-CRAFTS CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180237361-A1 | Aromatic Compositions and Methods for Obtaining Them | AHR, ARNT, TDO2 | DPP4 3133/4885AKR1C1 1001/4885OPRM1 4139/4885 |
| US-10259759-B2 | Cyclohexylbenzene composition | CYP1B1, CYP4B1, MCCC2 | DPP4 3908/4885AKR1C1 525/4885OPRM1 1831/4885 |
| US-20170001930-A1 | Cyclohexylbenzene Composition | CYP1B1, CYP4B1, MCCC2 | DPP4 3908/4885AKR1C1 525/4885OPRM1 1831/4885 |
| US-20170057895-A1 | Phenol Composition | CYP4B1, CYP26B1, CYP1B1 | DPP4 3314/4885AKR1C1 708/4885OPRM1 1825/4885 |
| US-10710945-B2 | Aromatic compositions and methods for obtaining them | AHR, ARNT, TDO2 | DPP4 3133/4885AKR1C1 1001/4885OPRM1 4139/4885 |
| US-20050054651-A1 | Compositions and methods for the treatment of disease associated with Trp-p8 expression | TRPC4, TRPC3, TRPC1 | DPP4 2440/4885AKR1C1 3419/4885OPRM1 578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.